Related Experiment Video

Updated: Sep 29, 2025

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

13.4K

GNG2 acts as a tumor suppressor in breast cancer through stimulating MRAS signaling

Anjiang Zhao1, Dan Li1, Xiongmin Mao1

  • 1The Key Laboratory of Laboratory Medical Diagnostics in the Ministry of Education and Department of Clinical Biochemistry, College of Laboratory Medicine, Chongqing Medical University, Chongqing, China.

Cell Death & Disease
|March 24, 2022
PubMed

Insights

G-protein gamma subunit 2 (GNG2) suppresses breast cancer growth by inhibiting cell proliferation and promoting apoptosis. Its interaction with muscle RAS oncogene homolog (MRAS) is key to this tumor-suppressive function.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • G-protein gamma subunit 2 (GNG2) plays a role in cell signaling, proliferation, and angiogenesis, but its function in tumorigenesis is not fully understood.
  • Breast cancer (BC) remains a significant health concern, necessitating research into novel therapeutic targets and understanding of underlying molecular mechanisms.

Purpose of the Study:

  • To investigate the role of GNG2 in breast cancer development and progression.
  • To elucidate the molecular mechanisms by which GNG2 affects BC cell behavior.
  • To explore the potential of GNG2 as a therapeutic target for breast cancer.

Main Methods:

  • Differential gene expression analysis using GEO and TCGA databases.
  • KEGG pathway enrichment analysis.
  • In vitro cell culture experiments (cell cycle, proliferation, apoptosis assays).
  • In vivo animal studies.
  • Western blotting and co-localization studies to assess protein interactions and signaling pathway activity (ERK, Akt, MRAS).
  • Fluorescence resonance energy transfer (FRET) to confirm direct interaction.

Main Results:

  • GNG2 expression was significantly reduced in all breast cancer subtypes.
  • GNG2 expression was independently associated with overall survival in luminal A and triple-negative breast cancer (TNBC) patients.
  • Overexpression of GNG2 inhibited BC cell proliferation, blocked the cell cycle, and promoted apoptosis in vitro.
  • GNG2 overexpression suppressed BC tumor growth in vivo.
  • GNG2 directly interacted with muscle RAS oncogene homolog (MRAS) at the cell membrane, inhibiting ERK and Akt signaling in an MRAS-dependent manner.

Conclusions:

  • GNG2 acts as a tumor suppressor in breast cancer.
  • The interaction between GNG2 and MRAS inhibits pro-tumorigenic Akt and ERK signaling, leading to reduced proliferation and increased apoptosis.
  • Modulating GNG2 expression or disrupting the GNG2-MRAS interaction presents a potential therapeutic strategy for breast cancer.

More Related Videos

Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer07:13

Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer

Published on: March 26, 2014

23.5K
Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

1.8K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.0K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.5K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.3K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K